ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹230 Cr | ₹5.05 Cr | ₹2.75 Cr | ₹52 Cr | ₹162 Cr |
What is the latest Total Non-Current Liabilities ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹230 Cr |
| Mar2025 | ₹5.05 Cr |
| Mar2024 | ₹2.75 Cr |
| Mar2023 | ₹52 Cr |
| Mar2022 | ₹162 Cr |
How is Total Non-Current Liabilities of ALEMBIC PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹230 Cr | 4,457.62 | |
| Mar2025 | ₹5.05 Cr | 83.64 | |
| Mar2024 | ₹2.75 Cr | -94.75 | |
| Mar2023 | ₹52 Cr | -67.66 | |
| Mar2022 | ₹162 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹15,751.6 Cr | 3.9% | -3% | -12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | 3.9% |
-3% |
-12.9% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses